BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 34864111)

  • 1. Identifying Brigham and Women's Hospital stage T2a cutaneous squamous cell carcinomas at risk of poor outcomes.
    Gupta N; Weitzman RE; Murad F; Koyfman SA; Smile TD; Chang MS; Maher JM; Schmults CD; Vidimos AT; Ruiz ES
    J Am Acad Dermatol; 2022 Jun; 86(6):1301-1308. PubMed ID: 34864111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the American Joint Committee on Cancer Seventh Edition and Brigham and Women's Hospital Cutaneous Squamous Cell Carcinoma Tumor Staging in Immunosuppressed Patients.
    Gonzalez JL; Cunningham K; Silverman R; Madan E; Nguyen BM
    Dermatol Surg; 2017 Jun; 43(6):784-791. PubMed ID: 28079640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extensive Perineural Invasion vs Nerve Caliber to Assess Cutaneous Squamous Cell Carcinoma Prognosis.
    Massey PR; Wang DM; Murad F; Mulvaney P; Moore K; Okhovat JP; Russell-Goldman E; Lin WM; Piris A; Huilgol SC; Ruiz ES; Schmults CD
    JAMA Dermatol; 2023 Dec; 159(12):1332-1338. PubMed ID: 37851425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stratification of Poor Outcomes for Cutaneous Squamous Cell Carcinoma in Immunosuppressed Patients Using the American Joint Committee on Cancer Eighth Edition and Brigham and Women's Hospital Staging Systems.
    Blechman AB; Carucci JA; Stevenson ML
    Dermatol Surg; 2019 Sep; 45(9):1117-1124. PubMed ID: 30640779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women's Hospital tumor staging for cutaneous squamous cell carcinoma.
    Karia PS; Jambusaria-Pahlajani A; Harrington DP; Murphy GF; Qureshi AA; Schmults CD
    J Clin Oncol; 2014 Feb; 32(4):327-34. PubMed ID: 24366933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
    Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD
    JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher metastasis and death rates in cutaneous squamous cell carcinomas with lymphovascular invasion.
    Kus KJB; Murad F; Smile TD; Chang M; Ashrafzadeh S; Zhou G; Ilori EO; Koyfman SA; Vidimos AT; Schmults CD; Ruiz ES
    J Am Acad Dermatol; 2022 Apr; 86(4):766-773. PubMed ID: 34774657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
    Levine DE; Karia PS; Schmults CD
    JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validating 4 Staging Systems for Cutaneous Squamous Cell Carcinoma Using Population-Based Data: A Nested Case-Control Study.
    Roscher I; Falk RS; Vos L; Clausen OPF; Helsing P; Gjersvik P; Robsahm TE
    JAMA Dermatol; 2018 Apr; 154(4):428-434. PubMed ID: 29516080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brigham and Women's Hospital tumor classification system for basal cell carcinoma identifies patients with risk of metastasis and death.
    Morgan FC; Ruiz ES; Karia PS; Besaw RJ; Neel VA; Schmults CD
    J Am Acad Dermatol; 2021 Sep; 85(3):582-587. PubMed ID: 33497751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous squamous cell carcinoma staging may influence management in users: A survey study.
    Patel VA; McCullum C; Sparks AD; Schmults CD; Arron ST; Jambusaria-Pahlajani A
    Cancer Med; 2022 Jan; 11(1):94-103. PubMed ID: 34796670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the eighth and the seventh editions of the American Joint Committee on Cancer staging system and the Brigham and Women's Hospital alternative staging system for cutaneous squamous cell carcinoma: Implications for clinical practice.
    Cañueto J; Burguillo J; Moyano-Bueno D; Viñolas-Cuadros A; Conde-Ferreirós A; Corchete-Sánchez LA; Pérez-Losada J; Román-Curto C
    J Am Acad Dermatol; 2019 Jan; 80(1):106-113.e2. PubMed ID: 30003984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study.
    Schmults CD; Karia PS; Carter JB; Han J; Qureshi AA
    JAMA Dermatol; 2013 May; 149(5):541-7. PubMed ID: 23677079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of primary cutaneous squamous cell carcinoma with perineural invasion: an 11-year cohort study.
    Carter JB; Johnson MM; Chua TL; Karia PS; Schmults CD
    JAMA Dermatol; 2013 Jan; 149(1):35-41. PubMed ID: 23324754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the American Joint Committee on Cancer Staging Manual, 8th Edition vs the Brigham and Women's Hospital Tumor Classification System for Cutaneous Squamous Cell Carcinoma.
    Ruiz ES; Karia PS; Besaw R; Schmults CD
    JAMA Dermatol; 2019 Jul; 155(7):819-825. PubMed ID: 30969315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes in intermediate-risk squamous cell carcinomas treated with Mohs micrographic surgery compared with wide local excision.
    Xiong DD; Beal BT; Varra V; Rodriguez M; Cundall H; Woody NM; Vidimos AT; Koyfman SA; Knackstedt TJ
    J Am Acad Dermatol; 2020 May; 82(5):1195-1204. PubMed ID: 31887322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tracking the risk factors associated with high-risk cSCC: A 10-year, Two-Institution, Greek study.
    Dimonitsas E; Champsas G; Kakagia D; Stavrianos S; Roussos S; Doryforou O; Neamonitou F; Soura E; Kostopoulos E; Christofidou E; Papadopulos O; Thymara I; Papadopulos NA; Stratigos A; Korkolopoulou P
    J BUON; 2021; 26(3):1148-1158. PubMed ID: 34268983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical outcomes of patients with invasive cutaneous squamous cell carcinoma treated with Mohs micrographic surgery: A 5-year, multicenter, prospective cohort study.
    Tschetter AJ; Campoli MR; Zitelli JA; Brodland DG
    J Am Acad Dermatol; 2020 Jan; 82(1):139-148. PubMed ID: 31279037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel Lymph Node Biopsy in High-Risk Cutaneous Squamous Cell Carcinoma: Analysis of a Large Size Retrospective Series.
    Tremblay-Abel V; Poulin MA; Blouin MM; Parent F; Perron É
    Dermatol Surg; 2021 Jul; 47(7):908-913. PubMed ID: 33988549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive Value of Sentinel Lymph Node Biopsy in Cutaneous Squamous Cell Carcinoma Based on the AJCC-8 and Brigham and Women's Hospital Staging Criteria.
    Tejera-Vaquerizo A; Cañueto J; Llombart B; Martorell-Calatayud A; Sanmartín O
    Dermatol Surg; 2020 Jul; 46(7):857-862. PubMed ID: 31567487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.